Pulmonary Artery Catheter Market Report 2026

Pulmonary Artery Catheter Market Overview

• Pulmonary Artery Catheter market size has reached to $1.26 billion in 2025 • Expected to grow to $1.58 billion in 2030 at a compound annual growth rate (CAGR) of 4.5% • Growth Driver: ising Lung Disease Incidence Drives Growth In Pulmonary Artery Catheter Market • Market Trend: Innovations In Pulmonary Artery Catheter Technology Enhancing Hemodynamic Monitoring And Minimally Invasive Procedures • North America was the largest region in 2025.

What Is Covered Under Pulmonary Artery Catheter Market?

A pulmonary artery catheter (PAC) is a specialized catheter used to measure pressures within the heart and pulmonary artery. It provides critical information about the cardiovascular system's function, particularly in patients with severe heart or lung conditions. PACs are commonly used in intensive care settings to monitor cardiac output, pulmonary artery pressure, and other hemodynamic parameters. The main products of pulmonary artery catheters are four lumen artery catheters, five lumen artery catheters, six lumen artery catheters, and others. A four-lumen artery catheter is a medical device with four separate channels used for various functions such as monitoring, medication delivery, and blood sampling in arterial access. It has various applications in intensive care units (ICUs), non-intensive care units (ICUs), and other modes of delivery, including hospitals, long-term care facilities, and others.

What Is The Pulmonary Artery Catheter Market Growth Forecast?

The pulmonary artery catheter market size is expected to see steady growth in the next few years. It will grow to $1.58 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to demand for advanced hemodynamic data, growth in complex ICU cases, technological improvements in catheter design, expansion of critical care infrastructure, emerging economies healthcare growth. Major trends in the forecast period include shift toward minimally invasive hemodynamic monitoring, increased use in high-risk cardiac procedures, rising preference for disposable catheters, focus on accuracy and safety enhancements, decline in routine use in low-risk patients.

Global Pulmonary Artery Catheter Market Segmentation

1) By Product: Four Lumen Artery Catheter, Five Lumen Artery Catheter, Six Lumen Artery Catheter, Other Product Types 2) By Application: Intensive Care Units (ICUs), Non-Intensive Care Units (ICUs), Other Applications 3) By Model Of Delivery: Hospitals, Long Term Care Facilities, Other End Users Subsegments: 1) By Four Lumen Artery Catheter: Standard Four Lumen Catheter, Thermodilution Four Lumen Catheter, Specialty Four Lumen Catheter 2) By Five Lumen Artery Catheter: Standard Five Lumen Catheter, Thermodilution Five Lumen Catheter, Specialty Five Lumen Catheter 3) By Six Lumen Artery Catheter: Standard Six Lumen Catheter, Thermodilution Six Lumen Catheter, Specialty Six Lumen Catheter 4) By Other Product Types: Introducer Sheath Catheters, Pressure Monitoring Catheters, Specialty Catheters, Disposable Pulmonary Artery Catheters

What Is The Driver Of The Pulmonary Artery Catheter Market?

The increasing incidence of lung diseases is expected to propel the growth of the pulmonary artery catheter market going forward. Lung diseases refer to medical conditions that affect the lungs and respiratory system, impairing their ability to take in oxygen and remove carbon dioxide. The rising incidence of lung diseases is due to increasing air pollution, as prolonged exposure to pollutants damages lung tissue and triggers chronic respiratory conditions. A pulmonary artery catheter measures heart and lung function by monitoring pressures within the pulmonary artery, helping diagnose and manage heart and lung diseases. For instance, in May 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, the age-adjusted prevalence of diagnosed chronic obstructive pulmonary disease (COPD) among adults aged 18 and older was 3.8%, with a higher prevalence in women (4.1%) compared to men (3.4%). Therefore, the increasing incidence of lung diseases is driving the growth of the pulmonary artery catheter industry.

Key Players In The Global Pulmonary Artery Catheter Market

Major companies operating in the pulmonary artery catheter market are Cardinal Health Corp, Medtronic Inc, Becton Dickinson And Company, Philips Healthcare Corp, Boston Scientific Corporation, Medline Industries Inc, B Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Smiths Medical Group, Teleflex Incorporated, Merit Medical Systems Inc, Vygon SA, ICU Medical Inc, Argon Medical Devices Inc, Biosensors International Group Ltd, Getinge AB, Osypka Medical GmbH, Pulsion Medical Systems SE, Cook Medical

Global Pulmonary Artery Catheter Market Trends and Insights

Major companies operating in the pulmonary artery catheter market are focused on developing innovative products such as endovascular catheters to enhance the accuracy of hemodynamic monitoring, improve patient safety, and facilitate minimally invasive procedures for assessing cardiac function and pulmonary pressures. The endovascular catheter is a specialized device used for accurate catheterization and monitoring of the pulmonary artery. For instance, in January 2024, Thrombolex Inc., a US-based medical device company, launched the BASHIR.035 and BASHIR S-B endovascular catheters for treating acute pulmonary embolism (PE). Designed to work with a 0.035 guidewire, these catheters feature a unique mechanism with an expandable infusion basket that enables targeted thrombolysis by delivering thrombolytics directly into the clot. This approach aims to rapidly restore blood flow, improving patient safety and reducing procedure time.

What Are Latest Mergers And Acquisitions In The Pulmonary Artery Catheter Market?

In September 2024, Becton, Dickinson and Company, a US-based medical device company, acquired Edwards Lifesciences Inc. for an undisclosed amount. The acquisition aims to strengthen BD's portfolio of critical care products and enhance its market position in advanced patient monitoring solutions. Edwards Lifesciences Inc. is a US-based medical device company that specializes in innovative heart valve solutions, hemodynamic monitoring, and critical care technologies.

Regional Outlook

North America was the largest region in the pulmonary artery catheter market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pulmonary Artery Catheter Market?

The pulmonary artery catheter market consists of sales of swan-ganz catheters, heparin-bonded catheters, multi-lumen catheters, temperature-sensing catheters, and pressure monitoring catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.